FBL and breast carcinoma: To determine whether the C/D box snoRNP complex signature differs in TNBC, we compared this signature (i.e., FBL, NOP56, NOP58, NHP2L1) in different breast cancer subtypes using the BRCA-TCGA dataset as described above for the ribosome biogenesis signature.